Scarica l'app Stockscreener
33.46
1.33%
0.44
Dopo l'orario di chiusura:
33.46
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ENOV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$33.02
Aprire:
$33.17
Volume 24 ore:
1.07M
Relative Volume:
1.00
Capitalizzazione di mercato:
$1.92B
Reddito:
$2.15B
Utile/perdita netta:
$-809.46M
Rapporto P/E:
-2.3986
EPS:
-13.95
Flusso di cassa netto:
$-38.98M
1 W Prestazione:
+4.14%
1M Prestazione:
+12.85%
6M Prestazione:
-24.47%
1 anno Prestazione:
-25.16%
Intervallo 1D:
$32.65
$33.60
Intervallo di 1 settimana:
$30.84
$33.95
Portata 52W:
$28.83
$49.83
Enovis Corp Stock (ENOV) Company Profile
Nome
Enovis Corp
Settore
Industria
Telefono
(302) 252-9160
Indirizzo
2711 CENTERVILLE ROAD, WILMINGTON
Confronta ENOV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
33.46 | 1.92B | 2.15B | -809.46M | -38.98M | -13.95 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-06-13 | Iniziato | JP Morgan | Neutral |
| 2024-02-13 | Iniziato | Stephens | Overweight |
| 2024-01-22 | Iniziato | UBS | Buy |
| 2024-01-03 | Iniziato | William Blair | Outperform |
| 2023-12-15 | Reiterato | Needham | Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-06-26 | Iniziato | Needham | Buy |
| 2023-05-12 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-10-11 | Iniziato | Goldman | Buy |
| 2022-09-12 | Iniziato | Canaccord Genuity | Buy |
| 2022-09-12 | Iniziato | Evercore ISI | Outperform |
| 2022-06-28 | Iniziato | Argus | Hold |
| 2022-06-27 | Ripresa | Loop Capital | Buy |
| 2022-06-16 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Enovis Corp Borsa (ENOV) Ultime notizie
Enovis Corporation Performance Slips Against NYSE Composite - Kalkine Media
Enovis (NYSE:ENOV shareholders incur further losses as stock declines 3.0% this week, taking five-year losses to 34% - simplywall.st
Transcript : Enovis Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02 - MarketScreener
Enovis to Present at Upcoming Investor Conferences in June - MSN
Enovis Corporation Q1 2025 Earnings Preview - MSN
Enovis to Participate in Upcoming Investor Conferences - The Manila Times
Enovis to Participate in Upcoming Investor Conferences | ENOV St - GuruFocus
Enovis Corporation Management to Participate in Upcoming Investor Conferences - Nasdaq
Enovis Corp (ENOV) Stock Price Down 3.51% on Jun 2 - GuruFocus
Optimistic Buy Rating for Enovis: Strong Growth, Margin Expansion, and Attractive Valuation - TipRanks
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo
Orthopedic Braces & Supports Market Focused Insights - GlobeNewswire
Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor - Yahoo Finance
Enovis Corp (ENOV) Trading Down 3.12% on May 21 - GuruFocus
Enovis holds annual meeting, stockholders vote on proposals By Investing.com - Investing.com India
Enovis holds annual meeting, stockholders vote on proposals - Investing.com
Enovis Holds Annual Meeting, Elects Board Directors - TipRanks
Medical Devices & SuppliesSpecialty Stocks Q1 Highlights: Enovis (NYSE:ENOV) - Yahoo Finance
Canaccord cuts Enovis stock target to $70, maintains Buy rating By Investing.com - Investing.com South Africa
Canaccord cuts Enovis stock target to $70, maintains Buy rating - Investing.com Australia
Enovis (ENOV): Canaccord Genuity Lowers Price Target to $70 | EN - GuruFocus
Canaccord Adjusts Price Target for Enovis (ENOV) Following Q1 Re - GuruFocus
Enovis price target lowered to $70 from $75 at Canaccord - TipRanks
Enovis Corporation (NYSE:ENOV) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Conflicted on These Industrial Goods Names: Carrier Global (CARR), BrightView Holdings (BV) and Enovis (ENOV) - The Globe and Mail
Enovis Corporation’s Strong Q1 2025 Earnings Call - TipRanks
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
UBS Adjusts Price Target on Enovis to $65 From $75, Maintains Buy Rating - marketscreener.com
JMP Securities Cuts Enovis (NYSE:ENOV) Price Target to $55.00 - Defense World
Enovis (ENOV) Q1 Earnings and Revenues Surpass Estimates - MSN
Enovis Reports Strong Q1 2025 Results, Updates Financial Outlook - MSN
Analysts Offer Insights on Industrial Goods Companies: Enovis (ENOV), Boeing (BA) and Arlo Technologies (ARLO) - The Globe and Mail
Enovis’ first-quarter net sales grow 8% to USD 559 million - Medical Buyer
Enovis stock price target cut to $55 by JMP Securities - Investing.com South Africa
Where Enovis Stands With Analysts - Benzinga
JMP Securities Adjusts Target Price for Enovis (ENOV) | ENOV Sto - GuruFocus
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Sto - GuruFocus
Is Enovis (NYSE:ENOV) A Risky Investment? - simplywall.st
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Stock News - GuruFocus
Enovis (ENOV) Price Target Reduced by Citizens JMP Amid Positive Outlook | ENOV Stock News - GuruFocus
Enovis: Q1 Earnings Snapshot - New Haven Register
Enovis Q1 2025 slides: revenue beats expectations, profit guidance lowered on tariffs - Investing.com
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Enovis Corp Azioni (ENOV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.54%
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):